Related Experiment Video

Updated: Sep 28, 2025

Automated Imaging and Analysis for the Quantification of Fluorescently Labeled Macropinosomes
11:01

Automated Imaging and Analysis for the Quantification of Fluorescently Labeled Macropinosomes

Published on: August 24, 2021

2.9K

KRAS Addiction Promotes Cancer Cell Adaptation in Harsh Microenvironment Through Macropinocytosis

Laetitia Seguin1

  • 1INSERM U1081, IRCAN, NICE, France. Laetitia.SEGUIN@univ-cotedazur.fr.

Sub-Cellular Biochemistry
|April 5, 2022
PubMed

Insights

KRAS mutations drive cancer by promoting cell survival and adaptation to scarcity through macropinocytosis. Understanding this process is key to developing new KRAS-targeted cancer therapies.

Area of Science:

  • Oncology
  • Cell Biology
  • Molecular Biology

Background:

  • KRAS is a frequently mutated oncogene in cancer, but therapies targeting it have largely failed due to complex signaling.
  • KRAS influences cancer progression by promoting cell survival, proliferation, metabolism, and adaptation to nutrient-poor tumor microenvironments.

Purpose of the Study:

  • To explore the role of KRAS-mediated macropinocytosis in cancer cell adaptation to nutrient scarcity.
  • To highlight the potential of targeting macropinocytosis as a therapeutic strategy against KRAS-driven cancers.

Main Methods:

  • Literature review on KRAS signaling and macropinocytosis.
  • Analysis of the biological processes regulated by KRAS, focusing on macropinocytosis.
  • Discussion of the implications of macropinocytosis in cancer cell survival and tumor growth.

Main Results:

  • KRAS activation promotes macropinocytosis, a nonselective form of endocytosis.
  • Macropinocytosis enables cancer cells to internalize extracellular fluids and proteins, crucial for survival in scarce conditions.
  • This process supports KRAS-driven tumor growth by providing essential nutrients and facilitating adaptation to adverse microenvironments.

Conclusions:

  • KRAS-mediated macropinocytosis is a critical survival mechanism for cancer cells under nutrient stress.
  • Targeting macropinocytosis represents a promising, alternative therapeutic strategy for KRAS-mutated cancers.
  • Further research into the KRAS-macropinocytosis axis is essential for developing novel anti-cancer treatments.
Keywords:
IntegrinKRAS addictionMacropinocytosisMicroenvironment sensing

More Related Videos

Measuring the pH, Redox Chemistries, and Degradative Capacity of Macropinosomes using Dual-Fluorophore Ratiometric Microscopy07:31

Measuring the pH, Redox Chemistries, and Degradative Capacity of Macropinosomes using Dual-Fluorophore Ratiometric Microscopy

Published on: August 19, 2021

2.5K
Visualizing Membrane Ruffle Formation using Scanning Electron Microscopy08:05

Visualizing Membrane Ruffle Formation using Scanning Electron Microscopy

Published on: May 27, 2021

2.7K

Related Concept Videos

Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.4K
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
6.5K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.7K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K